Eisenmenger’s syndrome screening: Difference between revisions
Jump to navigation
Jump to search
| Line 7: | Line 7: | ||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | ||
==Screening== | ==Screening== | ||
*[ | * There are currently no guidelines on using [[echocardiography]] to screen patients with [[CHD]] for the presence of [[Pulmonary hypertension|pulmonary arterial hypertension]]. | ||
* | * However, some parameters are recommended as pedictive of development of pulmonary arterial hypertension. | ||
* | |||
**Peak tricuspid regurgitation velocity | |||
**Ventricular basal diameter ratio | |||
**Systolic and/or diastolic ventricular eccentricity index. | |||
**RV outflow Doppler acceleration time | |||
**Pulmonary artery diameter | |||
**Inferior vena cava inspiratory collapse | |||
==References== | ==References== | ||
Revision as of 04:39, 27 January 2020
|
Eisenmenger’s syndrome Microchapters |
|
Diagnosis |
|---|
|
Eisenmenger’s syndrome ACC/AHA Guidelines for Evaluation of Patients |
|
Treatment |
|
Eisenmenger’s syndrome screening On the Web |
|
American Roentgen Ray Society Images of Eisenmenger’s syndrome screening |
|
Risk calculators and risk factors for Eisenmenger’s syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]
Overview
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
- There are currently no guidelines on using echocardiography to screen patients with CHD for the presence of pulmonary arterial hypertension.
- However, some parameters are recommended as pedictive of development of pulmonary arterial hypertension.
- Peak tricuspid regurgitation velocity
- Ventricular basal diameter ratio
- Systolic and/or diastolic ventricular eccentricity index.
- RV outflow Doppler acceleration time
- Pulmonary artery diameter
- Inferior vena cava inspiratory collapse